Thiazolidinediones as leads
A review
Keywords:
thiazolidinediones, peroxisome proliferator-activated receptor, type II diabetes mellitusAbstract
Thiazolidinediones are a class of well-established antidiabetic medications, similarly termed as glitazones. Thiazolidinedione structure has been a significant primary area of exploration, including plan and improvement of novel medications aimed at the administration of type 2 diabetes. Far reaching research has uncovered that the proposed antidiabetic movement in type II diabetes is because of their agonistic impact on peroxisome proliferator-initiated receptor (PPAR) having a place with the atomic receptor family. Glitazones have specific partiality to PPARγ. Pharmacology as well as science of thiazolidinedione as PPARγ agonists and the capability of more up to date analogs as double agonists of PPARs and other promising focuses for the treatment of type II diabetes. This audit features the thiazolidinedione which would direct the forthcoming examination in plan of new thiazolidinedione subsidiaries for the administration of type II diabetes.
Downloads
References
Cantrill, J.A., & Wood, J. (2005). “Diabetes Mellitus, In: Roger Walker and Clive Edwards, Clinical Pharmacy and Therapeutics”., 3rd edition, Churchill Livingstone, New York, 657-677.
Costantino, L., Rastelli, G., Gamberoni, M.C., & Barlocco, D. (2000). “Pharmacological approaches to the treatment of diabetic complications”. Experts Opinion on Therapeutic Patents, 10 (8), 1245- 1262.
Darwish, K. M., Salama, I., Mostafa, S., Gomaa, M. S., & Helal, M. A. (2016). “Design, synthesis, and biological evaluation of novel thiazolidinediones as PPARγ/FFAR1 dual agonists”. European Journal of Medicinal Chemistry, 109, 157-172.
Goel, B., Ram, T., Tyagi, R., Bansal, E., Kumar, A., Mukherjee, D., & Sinha, J. N. (1999). “2-Substituted-3-(4-bromo-2-carboxyphenyl)-5-methyl-4-thiazolidinones as potential anti-inflammatory agents”. European Journal of Medicinal Chemistry, 34(3), 265-269.
Iqbal, A. M., Khan, A. Y., Kalashetti, M. B., Belavagi, N. S., Gong, Y. D., & Khazi, I. A. M. (2012). “Synthesis, hypoglycemic and hypolipidemic activities of novel thiazolidinedione derivatives containing thiazole/triazole/oxadiazole ring”. European Journal of Medicinal Chemistry, 53, 308-315.
Issemann, I., & Green, S. (1990). “Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators”. Nature, 347(6294), 645-650.
Karalí, N., Gürsoy, A., Terzioglu, N., Özkírímlí, S., Özer, H., & Ekinci, A. C. (1998). “Synthesis and Preliminary CNS Depressant Activity Evaluation of New 3‐[(3‐Substituted‐5‐methyl‐4‐thiazolidinon‐2‐ylidene) hydrazono]‐1H‐2‐indolinones and 3‐[(2‐Thioxo‐3‐substituted‐4, 5‐imidazolidine‐dion‐1‐yl) imino]‐1H‐2‐indolinones”. Archiv der Pharmazie: An International Journal Pharmaceutical and Medicinal Chemistry, 331(7‐8), 254-258.
Kharbanda, C., Alam, M. S., Hamid, H., Javed, K., Bano, S., Ali, Y., Dhulap, A., Alam, P. & Pasha, M.Q. (2016). “Novel Piperine derivatives with Antidiabetic effect as PPAR‐γ agonists”. Chemical biology & drug design, 88(3), 354-362.
Lo, C. P., Shropshire, E. Y., & Croxall, W. J. (1953). “5-Aralkylidene-3-isobutyl-2, 4-thiazolidinediones”. Journal of the American Chemical Society, 75(19), 4845-4846.
Maccari, R., Vitale, R. M., Ottanà, R., Rocchiccioli, M., Marrazzo, A., Cardile, V., Graziano, A.C.E., Amodeo, P., Mura, U. & Del Corso, A. (2014). “Structure–activity relationships and molecular modelling of new 5-arylidene-4-thiazolidinone derivatives as aldose reductase inhibitors and potential anti-inflammatory agents”. European journal of medicinal chemistry, 81, 1-14.
Madhuri, M., Prasad, C., & Avupati, V. R. (2014). “In silico protein-ligand docking studies on thiazolidinediones as potential anticancer agents”. International Journal of Computer Applications, 95(6), 13-16.
Malik, S., Upadhyaya, P. K., & Miglani, S. (2011). “Thiazolidinediones: a plethro of biological load”. International Journal of PharmTech Research, 3(1), 62-75.
Monforte, P., Fenech, G., Basile, M., Ficarra, P., & Silvestro, A. (1979). “4‐Thiazolidinones and 2, 4‐thiazolidinediones from α‐mercaptopropionic acid and carbodiimides”. Journal of Heterocyclic Chemistry, 16(2), 341-345.
Murugan, R., Anbazhagan, S., & Narayanan, S. S. (2009). “Synthesis and in vivo antidiabetic activity of novel dispiropyrrolidines through [3+2] cycloaddition reactions with thiazolidinedione and rhodanine derivatives”. European Journal of Medicinal Chemistry, 44(8), 3272-3279.
Naim, M. J., Alam, O., Alam, M. J., Hassan, M. Q., Siddiqui, N., Naidu, V. G. M., & Alam, M. I. (2018). “Design, synthesis and molecular docking of thiazolidinedione-based benzene sulphonamide derivatives containing pyrazole core as potential anti-diabetic agents”. Bioorganic Chemistry, 76, 98-112.
Oguchi, M., Wada, K., Honma, H., Tanaka, A., Kaneko, T., Sakakibara, S., Ohsumi, J., Serizawa, N., Fujiwara, T., Horikoshi, H. and Fujita, T. (2000). “Molecular design, synthesis, and hypoglycemic activity of a series of thiazolidine-2, 4-diones”. Journal of Medicinal Chemistry, 43(16), 3052-3066.
Patel, K. D., Patel, C. N., & Patel, G. M. (2016). “Microwave assisted synthesis and antidiabetic activity of novel 5-[4-(substituted) benzylidine] thiazolidine-2, 4-dione”. Med Chem, 6(10), 647-651.
Ramachandran, R., Rani, M., & Kabilan, S. (2009). “Design, synthesis and biological evaluation of novel 2-[(2, 4-diaryl-3-azabicyclo [3.3. 1] nonan-9-ylidene) hydrazono]-1, 3-thiazolidin-4-ones as a new class of antimicrobial agents”. Bioorganic & medicinal chemistry letters, 19(10), 2819-2823.
Ratnawati, I. G. A. A., Sutapa, G. N., & Ratini, N. N. (2018). The concentration of radon gas in air-conditioned indoor: Air quality can increase the potential of lung cancer. International Journal of Physical Sciences and Engineering, 2(2), 111–119. https://doi.org/10.29332/ijpse.v2n2.169
Saraswati, P. A. I. ., Gunawan, I. M. K., & Budiyasa, D. G. A. (2021). Overview of glomerulus filtration in type 2 of diabetes mellitus at Sanjiwani Gianyar hospital year of 2018-2019. International Journal of Health & Medical Sciences, 4(1), 50-55. https://doi.org/10.31295/ijhms.v4n1.726
Sohda, T., Mizuno, K., Momose, Y., Ikeda, H., Fujita, T., & Meguro, K. (1992). “Studies on antidiabetic agents. 11. Novel thiazolidinedione derivatives as potent hypoglycemic and hypolipidemic agents”. Journal of medicinal chemistry, 35(14), 2617-2626.
Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2021). Health and treatment of diabetes mellitus. International Journal of Health Sciences, 5(1), i-v. https://doi.org/10.53730/ijhs.v5n1.2864
Verma, S. K., & Thareja, S. (2016). “Molecular docking assisted 3D-QSAR study of benzylidene-2, 4-thiazolidinedione derivatives as PTP-1B inhibitors for the management of Type-2 diabetes mellitus”. RSC Advances, 6(40), 33857-33867.
Yki-Jarvinen, H. (2004). “Thiazolidinediones”. New England Journal of Medicine, 351, 1106-1118.
Zask, A., Jirkovsky, I., Nowicki, J. W., & McCaleb, M. L. (1990). “Synthesis and antihyperglycemic activity of novel 5-(naphthalenylsulfonyl)-2, 4-thiazolidinediones”. Journal of Medicinal Chemistry, 33(5), 1418-1423.
Zhang, J., Wang, X. J., Liu, X., Huan, Y., Yang, M. M., Shen, Z. F., Jia, W.Q., Jing, Z., Wang, S.Q., Xu, W.R. and Cheng, X.C. (2017). “Design, synthesis and evaluation of a series of 3-or 4-alkoxy substituted phenoxy derivatives as PPARs agonists. Oncotarget, 8(13), 20766.
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
